Literature DB >> 24788087

Knockdown of acid-sensing ion channel 1a (ASIC1a) suppresses disease phenotype in SCA1 mouse model.

Parminder J S Vig1, Scoty M Hearst, Qingmei Shao, Maripar E Lopez.   

Abstract

The mutated ataxin-1 protein in spinocerebellar ataxia 1 (SCA1) targets Purkinje cells (PCs) of the cerebellum and causes progressive ataxia due to loss of PCs and neurons of the brainstem. The exact mechanism of this cellular loss is still not clear. Currently, there are no treatments for SCA1; however, understanding of the mechanisms that regulate SCA1 pathology is essential for devising new therapies for SCA1 patients. We previously established a connection between the loss of intracellular calcium-buffering and calcium-signalling proteins with initiation of neurodegeneration in SCA1 transgenic (Tg) mice. Recently, acid-sensing ion channel 1a (ASIC1a) have been implicated in calcium-mediated toxicity in many brain disorders. Here, we report generating SCA1 Tg mice in the ASIC1a knockout (KO) background and demonstrate that the deletion of ASIC1a gene expression causes suppression of the SCA1 disease phenotype. Loss of the ASIC1a channel in SCA1/ASIC1a KO mice resulted in the improvement of motor deficit and decreased PC degeneration. Interestingly, the expression of the ASIC1 variant, ASIC1b, was upregulated in the cerebellum of both SCA1/ASIC1a KO and ASIC1a KO animals as compared to the wild-type (WT) and SCA1 Tg mice. Further, these SCA1/ASIC1a KO mice exhibited translocation of PC calcium-binding protein calbindin-D28k from the nucleus to the cytosol in young animals, which otherwise have both cytosolic and nuclear localization. Furthermore, in addition to higher expression of calcium-buffering protein parvalbumin, PCs of the older SCA1/ASIC1a KO mice showed a decrease in morphologic abnormalities as compared to the age-matched SCA1 animals. Our data suggest that ASIC1a may be a mediator of SCA1 pathogenesis and targeting ASIC1a could be a novel approach to treat SCA1.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24788087     DOI: 10.1007/s12311-014-0563-6

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  89 in total

Review 1.  Acid-sensing ion channels: advances, questions and therapeutic opportunities.

Authors:  John A Wemmie; Margaret P Price; Michael J Welsh
Journal:  Trends Neurosci       Date:  2006-08-07       Impact factor: 13.837

2.  Heteromeric acid-sensing ion channels (ASICs) composed of ASIC2b and ASIC1a display novel channel properties and contribute to acidosis-induced neuronal death.

Authors:  Thomas W Sherwood; Kirsten G Lee; Matthew G Gormley; Candice C Askwith
Journal:  J Neurosci       Date:  2011-06-29       Impact factor: 6.167

Review 3.  Ca2+ -permeable acid-sensing ion channels and ischemic brain injury.

Authors:  Z-G Xiong; X-P Chu; R P Simon
Journal:  J Membr Biol       Date:  2006-04-17       Impact factor: 1.843

4.  ASIC1a polymorphism is associated with temporal lobe epilepsy.

Authors:  Rui-Juan Lv; Jin-Sheng He; Yuan-Hui Fu; Ya-Qing Zhang; Xiao-Qiu Shao; Li-Wen Wu; Qiang Lu; Li-Ri Jin; Hui Liu
Journal:  Epilepsy Res       Date:  2011-06-12       Impact factor: 3.045

5.  The acid-activated ion channel ASIC contributes to synaptic plasticity, learning, and memory.

Authors:  John A Wemmie; Jianguo Chen; Candice C Askwith; Alesia M Hruska-Hageman; Margaret P Price; Brian C Nolan; Patrick G Yoder; Ejvis Lamani; Toshinori Hoshi; John H Freeman; Michael J Welsh
Journal:  Neuron       Date:  2002-04-25       Impact factor: 17.173

6.  Decreased parvalbumin immunoreactivity in surviving Purkinje cells of patients with spinocerebellar ataxia-1.

Authors:  P J Vig; J D Fratkin; D Desaiah; R D Currier; S H Subramony
Journal:  Neurology       Date:  1996-07       Impact factor: 9.910

7.  Acidosis-induced zinc-dependent death of cultured cerebellar granule neurons.

Authors:  Nikolay K Isaev; Elena V Stelmashook; Sergey V Lukin; Dorette Freyer; Philipp Mergenthaler; Dmitry B Zorov
Journal:  Cell Mol Neurobiol       Date:  2010-04-07       Impact factor: 5.046

8.  Black mamba venom peptides target acid-sensing ion channels to abolish pain.

Authors:  Sylvie Diochot; Anne Baron; Miguel Salinas; Dominique Douguet; Sabine Scarzello; Anne-Sophie Dabert-Gay; Delphine Debayle; Valérie Friend; Abdelkrim Alloui; Michel Lazdunski; Eric Lingueglia
Journal:  Nature       Date:  2012-10-03       Impact factor: 49.962

9.  SCA1 transgenic mice: a model for neurodegeneration caused by an expanded CAG trinucleotide repeat.

Authors:  E N Burright; H B Clark; A Servadio; T Matilla; R M Feddersen; W S Yunis; L A Duvick; H Y Zoghbi; H T Orr
Journal:  Cell       Date:  1995-09-22       Impact factor: 41.582

10.  Acid sensing ion channels in dorsal spinal cord neurons.

Authors:  Anne Baron; Nicolas Voilley; Michel Lazdunski; Eric Lingueglia
Journal:  J Neurosci       Date:  2008-02-06       Impact factor: 6.167

View more
  5 in total

Review 1.  ASICs and neuropeptides.

Authors:  Jonathan S Vick; Candice C Askwith
Journal:  Neuropharmacology       Date:  2015-01-12       Impact factor: 5.250

Review 2.  Acid-Sensing Ion Channels in Glial Cells.

Authors:  Victoria Cegielski; Rohan Chakrabarty; Shinghua Ding; Michael J Wacker; Paula Monaghan-Nichols; Xiang-Ping Chu
Journal:  Membranes (Basel)       Date:  2022-01-20

Review 3.  Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease.

Authors:  David D Bushart; Geoffrey G Murphy; Vikram G Shakkottai
Journal:  Ann Transl Med       Date:  2016-01

Review 4.  Acid-Sensing Ion Channels as Potential Therapeutic Targets in Neurodegeneration and Neuroinflammation.

Authors:  Audrey Ortega-Ramírez; Rosario Vega; Enrique Soto
Journal:  Mediators Inflamm       Date:  2017-09-19       Impact factor: 4.711

Review 5.  Acid-Sensing Ion Channels: Focus on Physiological and Some Pathological Roles in the Brain.

Authors:  Maksim Storozhuk; Andrii Cherninskyi; Oleksandr Maximyuk; Dmytro Isaev; Oleg Krishtal
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.